These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1350613)

  • 1. Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use.
    Liester MB; Grob CS; Bravo GL; Walsh RN
    J Nerv Ment Dis; 1992 Jun; 180(6):345-52; discussion 353-4. PubMed ID: 1350613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MDMA-neurotoxicity controversy: implications for clinical research with novel psychoactive drugs.
    Grob CS; Bravo GL; Walsh RN; Liester MB
    J Nerv Ment Dis; 1992 Jun; 180(6):355-6. PubMed ID: 1350614
    [No Abstract]   [Full Text] [Related]  

  • 3. Ecstacy: a review of MDMA and MDA.
    Climko RP; Roehrich H; Sweeney DR; Al-Razi J
    Int J Psychiatry Med; 1986-1987; 16(4):359-72. PubMed ID: 2881902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second thoughts on 3,4-methylenedioxymethamphetamine (MDMA) neurotoxicity.
    Grob C; Bravo G; Walsh R
    Arch Gen Psychiatry; 1990 Mar; 47(3):288-9. PubMed ID: 1968330
    [No Abstract]   [Full Text] [Related]  

  • 5. Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.
    Peroutka SJ; Newman H; Harris H
    Neuropsychopharmacology; 1988 Dec; 1(4):273-7. PubMed ID: 2908020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective reports of the effects of MDMA in a clinical setting.
    Greer G; Tolbert R
    J Psychoactive Drugs; 1986; 18(4):319-27. PubMed ID: 2880946
    [No Abstract]   [Full Text] [Related]  

  • 7. Flashbacks following MDMA.
    McGuire P; Fahy T
    Br J Psychiatry; 1992 Feb; 160():276. PubMed ID: 1347241
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.
    Ricaurte GA; Finnegan KT; Irwin I; Langston JW
    Ann N Y Acad Sci; 1990; 600():699-708; discussion 708-10. PubMed ID: 1701292
    [No Abstract]   [Full Text] [Related]  

  • 9. 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.
    Steele TD; McCann UD; Ricaurte GA
    Addiction; 1994 May; 89(5):539-51. PubMed ID: 7913850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
    Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
    Nervenarzt; 1996 May; 67(5):369-80. PubMed ID: 9005345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinforcing subjective effects of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") may be separable from its neurotoxic actions: clinical evidence.
    McCann UD; Ricaurte GA
    J Clin Psychopharmacol; 1993 Jun; 13(3):214-7. PubMed ID: 8102623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.
    Rattray M
    Essays Biochem; 1991; 26():77-87. PubMed ID: 1685707
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of conditioned taste aversions produced by MDMA and d-amphetamine.
    Lin HQ; Atrens DM; Christie MJ; Jackson DM; McGregor IS
    Pharmacol Biochem Behav; 1993 Sep; 46(1):153-6. PubMed ID: 7902981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Ecstasy" and "ice": the return of the amphetamines].
    Kaminer Y; Zemishlany Z
    Harefuah; 1991 Jun; 120(12):727-9. PubMed ID: 1683637
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives.
    Bronson ME; Barrios-Zambrano L; Jiang W; Clark CR; DeRuiter J; Newland MC
    Drug Alcohol Depend; 1994 Dec; 36(3):161-6. PubMed ID: 7889806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lasting neuropsychiatric sequelae of (+-)methylenedioxymethamphetamine ('ecstasy') in recreational users.
    McCann UD; Ricaurte GA
    J Clin Psychopharmacol; 1991 Oct; 11(5):302-5. PubMed ID: 1684975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of MDMA ('ecstasy') on firing rates of serotonergic, dopaminergic, and noradrenergic neurons in the rat.
    Piercey MF; Lum JT; Palmer JR
    Brain Res; 1990 Sep; 526(2):203-6. PubMed ID: 1979517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ecstasy and the dance of death.
    Greer G
    BMJ; 1992 Sep; 305(6856):775. PubMed ID: 1358374
    [No Abstract]   [Full Text] [Related]  

  • 19. Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug.
    Solowij N; Hall W; Lee N
    Br J Addict; 1992 Aug; 87(8):1161-72. PubMed ID: 1354992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA ("ecstasy") and panic disorder: induction by a single dose.
    McCann UD; Ricaurte GA
    Biol Psychiatry; 1992 Nov; 32(10):950-3. PubMed ID: 1361366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.